Fundraising Fox

Syndex

Santa Monica, US · Founded 2022 · 1 known investors

syndex.bio ↗

Syndex develops mcPCR (methyl copying PCR), a proprietary platform technology that amplifies DNA while preserving methylation patterns, addressing the challenge of low DNA levels in clinical samples. The technology targets clinical applications including oncology and early cancer detection, residual disease and treatment monitoring, drug development, and chronic disease detection.

BiotechDeep TechMedical Devices

Founders & leadership

GP
Geoff Paul SmithExecutive Officer, Director
GS
Geoff SmithFounder & CEO
JB
Jason BetleyChief Product Officer

Investors · 1

OMX VenturesLincolnshire

Reported raises · per SEC filings

Form D private placements
▶$15.5MraisedMar 2025 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoff Paul SmithExecutive Officer, Director
Offering amount
$15.5M
Amount sold
$15.5M
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.